Global Parenteral Dosage Form Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Parenteral Dosage Form market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Parenteral Dosage Form Industry Forecast” looks at past sales and reviews total world Parenteral Dosage Form sales in 2023, providing a comprehensive analysis by region and market sector of projected Parenteral Dosage Form sales for 2024 through 2030. With Parenteral Dosage Form sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Parenteral Dosage Form industry.
This Insight Report provides a comprehensive analysis of the global Parenteral Dosage Form landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Parenteral Dosage Form portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Parenteral Dosage Form market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Parenteral Dosage Form and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Parenteral Dosage Form.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report presents a comprehensive overview, market shares, and growth opportunities of Parenteral Dosage Form market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
What is the 10-year outlook for the global Parenteral Dosage Form market?
What factors are driving Parenteral Dosage Form market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Parenteral Dosage Form market opportunities vary by end market size?
How does Parenteral Dosage Form break out type, application?
The global Parenteral Dosage Form market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Parenteral Dosage Form Industry Forecast” looks at past sales and reviews total world Parenteral Dosage Form sales in 2023, providing a comprehensive analysis by region and market sector of projected Parenteral Dosage Form sales for 2024 through 2030. With Parenteral Dosage Form sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Parenteral Dosage Form industry.
This Insight Report provides a comprehensive analysis of the global Parenteral Dosage Form landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Parenteral Dosage Form portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Parenteral Dosage Form market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Parenteral Dosage Form and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Parenteral Dosage Form.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report presents a comprehensive overview, market shares, and growth opportunities of Parenteral Dosage Form market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
- Emulsions for Injection
- Powders for Injection
- Gels for Injection
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Ashland
- Tepnel Pharma Services
- Ascendia Pharmaceuticals
- Thermo Fisher Scientific
- ProJect Pharmaceutics
- Lonza
- BOC Sciences
What is the 10-year outlook for the global Parenteral Dosage Form market?
What factors are driving Parenteral Dosage Form market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Parenteral Dosage Form market opportunities vary by end market size?
How does Parenteral Dosage Form break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Parenteral Dosage Form Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Parenteral Dosage Form by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Parenteral Dosage Form by Country/Region, 2019, 2023 & 2030
2.2 Parenteral Dosage Form Segment by Type
2.2.1 Emulsions for Injection
2.2.2 Powders for Injection
2.2.3 Gels for Injection
2.3 Parenteral Dosage Form Sales by Type
2.3.1 Global Parenteral Dosage Form Sales Market Share by Type (2019-2024)
2.3.2 Global Parenteral Dosage Form Revenue and Market Share by Type (2019-2024)
2.3.3 Global Parenteral Dosage Form Sale Price by Type (2019-2024)
2.4 Parenteral Dosage Form Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Parenteral Dosage Form Sales by Application
2.5.1 Global Parenteral Dosage Form Sale Market Share by Application (2019-2024)
2.5.2 Global Parenteral Dosage Form Revenue and Market Share by Application (2019-2024)
2.5.3 Global Parenteral Dosage Form Sale Price by Application (2019-2024)
3 GLOBAL PARENTERAL DOSAGE FORM BY COMPANY
3.1 Global Parenteral Dosage Form Breakdown Data by Company
3.1.1 Global Parenteral Dosage Form Annual Sales by Company (2019-2024)
3.1.2 Global Parenteral Dosage Form Sales Market Share by Company (2019-2024)
3.2 Global Parenteral Dosage Form Annual Revenue by Company (2019-2024)
3.2.1 Global Parenteral Dosage Form Revenue by Company (2019-2024)
3.2.2 Global Parenteral Dosage Form Revenue Market Share by Company (2019-2024)
3.3 Global Parenteral Dosage Form Sale Price by Company
3.4 Key Manufacturers Parenteral Dosage Form Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Parenteral Dosage Form Product Location Distribution
3.4.2 Players Parenteral Dosage Form Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PARENTERAL DOSAGE FORM BY GEOGRAPHIC REGION
4.1 World Historic Parenteral Dosage Form Market Size by Geographic Region (2019-2024)
4.1.1 Global Parenteral Dosage Form Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Parenteral Dosage Form Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Parenteral Dosage Form Market Size by Country/Region (2019-2024)
4.2.1 Global Parenteral Dosage Form Annual Sales by Country/Region (2019-2024)
4.2.2 Global Parenteral Dosage Form Annual Revenue by Country/Region (2019-2024)
4.3 Americas Parenteral Dosage Form Sales Growth
4.4 APAC Parenteral Dosage Form Sales Growth
4.5 Europe Parenteral Dosage Form Sales Growth
4.6 Middle East & Africa Parenteral Dosage Form Sales Growth
5 AMERICAS
5.1 Americas Parenteral Dosage Form Sales by Country
5.1.1 Americas Parenteral Dosage Form Sales by Country (2019-2024)
5.1.2 Americas Parenteral Dosage Form Revenue by Country (2019-2024)
5.2 Americas Parenteral Dosage Form Sales by Type
5.3 Americas Parenteral Dosage Form Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Parenteral Dosage Form Sales by Region
6.1.1 APAC Parenteral Dosage Form Sales by Region (2019-2024)
6.1.2 APAC Parenteral Dosage Form Revenue by Region (2019-2024)
6.2 APAC Parenteral Dosage Form Sales by Type
6.3 APAC Parenteral Dosage Form Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Parenteral Dosage Form by Country
7.1.1 Europe Parenteral Dosage Form Sales by Country (2019-2024)
7.1.2 Europe Parenteral Dosage Form Revenue by Country (2019-2024)
7.2 Europe Parenteral Dosage Form Sales by Type
7.3 Europe Parenteral Dosage Form Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Parenteral Dosage Form by Country
8.1.1 Middle East & Africa Parenteral Dosage Form Sales by Country (2019-2024)
8.1.2 Middle East & Africa Parenteral Dosage Form Revenue by Country (2019-2024)
8.2 Middle East & Africa Parenteral Dosage Form Sales by Type
8.3 Middle East & Africa Parenteral Dosage Form Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Parenteral Dosage Form
10.3 Manufacturing Process Analysis of Parenteral Dosage Form
10.4 Industry Chain Structure of Parenteral Dosage Form
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Parenteral Dosage Form Distributors
11.3 Parenteral Dosage Form Customer
12 WORLD FORECAST REVIEW FOR PARENTERAL DOSAGE FORM BY GEOGRAPHIC REGION
12.1 Global Parenteral Dosage Form Market Size Forecast by Region
12.1.1 Global Parenteral Dosage Form Forecast by Region (2025-2030)
12.1.2 Global Parenteral Dosage Form Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Parenteral Dosage Form Forecast by Type
12.7 Global Parenteral Dosage Form Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Ashland
13.1.1 Ashland Company Information
13.1.2 Ashland Parenteral Dosage Form Product Portfolios and Specifications
13.1.3 Ashland Parenteral Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Ashland Main Business Overview
13.1.5 Ashland Latest Developments
13.2 Tepnel Pharma Services
13.2.1 Tepnel Pharma Services Company Information
13.2.2 Tepnel Pharma Services Parenteral Dosage Form Product Portfolios and Specifications
13.2.3 Tepnel Pharma Services Parenteral Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Tepnel Pharma Services Main Business Overview
13.2.5 Tepnel Pharma Services Latest Developments
13.3 Ascendia Pharmaceuticals
13.3.1 Ascendia Pharmaceuticals Company Information
13.3.2 Ascendia Pharmaceuticals Parenteral Dosage Form Product Portfolios and Specifications
13.3.3 Ascendia Pharmaceuticals Parenteral Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Ascendia Pharmaceuticals Main Business Overview
13.3.5 Ascendia Pharmaceuticals Latest Developments
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Information
13.4.2 Thermo Fisher Scientific Parenteral Dosage Form Product Portfolios and Specifications
13.4.3 Thermo Fisher Scientific Parenteral Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Thermo Fisher Scientific Main Business Overview
13.4.5 Thermo Fisher Scientific Latest Developments
13.5 ProJect Pharmaceutics
13.5.1 ProJect Pharmaceutics Company Information
13.5.2 ProJect Pharmaceutics Parenteral Dosage Form Product Portfolios and Specifications
13.5.3 ProJect Pharmaceutics Parenteral Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 ProJect Pharmaceutics Main Business Overview
13.5.5 ProJect Pharmaceutics Latest Developments
13.6 Lonza
13.6.1 Lonza Company Information
13.6.2 Lonza Parenteral Dosage Form Product Portfolios and Specifications
13.6.3 Lonza Parenteral Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Lonza Main Business Overview
13.6.5 Lonza Latest Developments
13.7 BOC Sciences
13.7.1 BOC Sciences Company Information
13.7.2 BOC Sciences Parenteral Dosage Form Product Portfolios and Specifications
13.7.3 BOC Sciences Parenteral Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 BOC Sciences Main Business Overview
13.7.5 BOC Sciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Parenteral Dosage Form Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Parenteral Dosage Form by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Parenteral Dosage Form by Country/Region, 2019, 2023 & 2030
2.2 Parenteral Dosage Form Segment by Type
2.2.1 Emulsions for Injection
2.2.2 Powders for Injection
2.2.3 Gels for Injection
2.3 Parenteral Dosage Form Sales by Type
2.3.1 Global Parenteral Dosage Form Sales Market Share by Type (2019-2024)
2.3.2 Global Parenteral Dosage Form Revenue and Market Share by Type (2019-2024)
2.3.3 Global Parenteral Dosage Form Sale Price by Type (2019-2024)
2.4 Parenteral Dosage Form Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Parenteral Dosage Form Sales by Application
2.5.1 Global Parenteral Dosage Form Sale Market Share by Application (2019-2024)
2.5.2 Global Parenteral Dosage Form Revenue and Market Share by Application (2019-2024)
2.5.3 Global Parenteral Dosage Form Sale Price by Application (2019-2024)
3 GLOBAL PARENTERAL DOSAGE FORM BY COMPANY
3.1 Global Parenteral Dosage Form Breakdown Data by Company
3.1.1 Global Parenteral Dosage Form Annual Sales by Company (2019-2024)
3.1.2 Global Parenteral Dosage Form Sales Market Share by Company (2019-2024)
3.2 Global Parenteral Dosage Form Annual Revenue by Company (2019-2024)
3.2.1 Global Parenteral Dosage Form Revenue by Company (2019-2024)
3.2.2 Global Parenteral Dosage Form Revenue Market Share by Company (2019-2024)
3.3 Global Parenteral Dosage Form Sale Price by Company
3.4 Key Manufacturers Parenteral Dosage Form Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Parenteral Dosage Form Product Location Distribution
3.4.2 Players Parenteral Dosage Form Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PARENTERAL DOSAGE FORM BY GEOGRAPHIC REGION
4.1 World Historic Parenteral Dosage Form Market Size by Geographic Region (2019-2024)
4.1.1 Global Parenteral Dosage Form Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Parenteral Dosage Form Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Parenteral Dosage Form Market Size by Country/Region (2019-2024)
4.2.1 Global Parenteral Dosage Form Annual Sales by Country/Region (2019-2024)
4.2.2 Global Parenteral Dosage Form Annual Revenue by Country/Region (2019-2024)
4.3 Americas Parenteral Dosage Form Sales Growth
4.4 APAC Parenteral Dosage Form Sales Growth
4.5 Europe Parenteral Dosage Form Sales Growth
4.6 Middle East & Africa Parenteral Dosage Form Sales Growth
5 AMERICAS
5.1 Americas Parenteral Dosage Form Sales by Country
5.1.1 Americas Parenteral Dosage Form Sales by Country (2019-2024)
5.1.2 Americas Parenteral Dosage Form Revenue by Country (2019-2024)
5.2 Americas Parenteral Dosage Form Sales by Type
5.3 Americas Parenteral Dosage Form Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Parenteral Dosage Form Sales by Region
6.1.1 APAC Parenteral Dosage Form Sales by Region (2019-2024)
6.1.2 APAC Parenteral Dosage Form Revenue by Region (2019-2024)
6.2 APAC Parenteral Dosage Form Sales by Type
6.3 APAC Parenteral Dosage Form Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Parenteral Dosage Form by Country
7.1.1 Europe Parenteral Dosage Form Sales by Country (2019-2024)
7.1.2 Europe Parenteral Dosage Form Revenue by Country (2019-2024)
7.2 Europe Parenteral Dosage Form Sales by Type
7.3 Europe Parenteral Dosage Form Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Parenteral Dosage Form by Country
8.1.1 Middle East & Africa Parenteral Dosage Form Sales by Country (2019-2024)
8.1.2 Middle East & Africa Parenteral Dosage Form Revenue by Country (2019-2024)
8.2 Middle East & Africa Parenteral Dosage Form Sales by Type
8.3 Middle East & Africa Parenteral Dosage Form Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Parenteral Dosage Form
10.3 Manufacturing Process Analysis of Parenteral Dosage Form
10.4 Industry Chain Structure of Parenteral Dosage Form
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Parenteral Dosage Form Distributors
11.3 Parenteral Dosage Form Customer
12 WORLD FORECAST REVIEW FOR PARENTERAL DOSAGE FORM BY GEOGRAPHIC REGION
12.1 Global Parenteral Dosage Form Market Size Forecast by Region
12.1.1 Global Parenteral Dosage Form Forecast by Region (2025-2030)
12.1.2 Global Parenteral Dosage Form Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Parenteral Dosage Form Forecast by Type
12.7 Global Parenteral Dosage Form Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Ashland
13.1.1 Ashland Company Information
13.1.2 Ashland Parenteral Dosage Form Product Portfolios and Specifications
13.1.3 Ashland Parenteral Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Ashland Main Business Overview
13.1.5 Ashland Latest Developments
13.2 Tepnel Pharma Services
13.2.1 Tepnel Pharma Services Company Information
13.2.2 Tepnel Pharma Services Parenteral Dosage Form Product Portfolios and Specifications
13.2.3 Tepnel Pharma Services Parenteral Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Tepnel Pharma Services Main Business Overview
13.2.5 Tepnel Pharma Services Latest Developments
13.3 Ascendia Pharmaceuticals
13.3.1 Ascendia Pharmaceuticals Company Information
13.3.2 Ascendia Pharmaceuticals Parenteral Dosage Form Product Portfolios and Specifications
13.3.3 Ascendia Pharmaceuticals Parenteral Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Ascendia Pharmaceuticals Main Business Overview
13.3.5 Ascendia Pharmaceuticals Latest Developments
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Information
13.4.2 Thermo Fisher Scientific Parenteral Dosage Form Product Portfolios and Specifications
13.4.3 Thermo Fisher Scientific Parenteral Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Thermo Fisher Scientific Main Business Overview
13.4.5 Thermo Fisher Scientific Latest Developments
13.5 ProJect Pharmaceutics
13.5.1 ProJect Pharmaceutics Company Information
13.5.2 ProJect Pharmaceutics Parenteral Dosage Form Product Portfolios and Specifications
13.5.3 ProJect Pharmaceutics Parenteral Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 ProJect Pharmaceutics Main Business Overview
13.5.5 ProJect Pharmaceutics Latest Developments
13.6 Lonza
13.6.1 Lonza Company Information
13.6.2 Lonza Parenteral Dosage Form Product Portfolios and Specifications
13.6.3 Lonza Parenteral Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Lonza Main Business Overview
13.6.5 Lonza Latest Developments
13.7 BOC Sciences
13.7.1 BOC Sciences Company Information
13.7.2 BOC Sciences Parenteral Dosage Form Product Portfolios and Specifications
13.7.3 BOC Sciences Parenteral Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 BOC Sciences Main Business Overview
13.7.5 BOC Sciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Parenteral Dosage Form Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Parenteral Dosage Form Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Emulsions for Injection
Table 4. Major Players of Powders for Injection
Table 5. Major Players of Gels for Injection
Table 6. Global Parenteral Dosage Form Sales by Type (2019-2024) & (Kiloton)
Table 7. Global Parenteral Dosage Form Sales Market Share by Type (2019-2024)
Table 8. Global Parenteral Dosage Form Revenue by Type (2019-2024) & ($ million)
Table 9. Global Parenteral Dosage Form Revenue Market Share by Type (2019-2024)
Table 10. Global Parenteral Dosage Form Sale Price by Type (2019-2024) & (US$/Ton)
Table 11. Global Parenteral Dosage Form Sales by Application (2019-2024) & (Kiloton)
Table 12. Global Parenteral Dosage Form Sales Market Share by Application (2019-2024)
Table 13. Global Parenteral Dosage Form Revenue by Application (2019-2024)
Table 14. Global Parenteral Dosage Form Revenue Market Share by Application (2019-2024)
Table 15. Global Parenteral Dosage Form Sale Price by Application (2019-2024) & (US$/Ton)
Table 16. Global Parenteral Dosage Form Sales by Company (2019-2024) & (Kiloton)
Table 17. Global Parenteral Dosage Form Sales Market Share by Company (2019-2024)
Table 18. Global Parenteral Dosage Form Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Parenteral Dosage Form Revenue Market Share by Company (2019-2024)
Table 20. Global Parenteral Dosage Form Sale Price by Company (2019-2024) & (US$/Ton)
Table 21. Key Manufacturers Parenteral Dosage Form Producing Area Distribution and Sales Area
Table 22. Players Parenteral Dosage Form Products Offered
Table 23. Parenteral Dosage Form Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Parenteral Dosage Form Sales by Geographic Region (2019-2024) & (Kiloton)
Table 27. Global Parenteral Dosage Form Sales Market Share Geographic Region (2019-2024)
Table 28. Global Parenteral Dosage Form Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Parenteral Dosage Form Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Parenteral Dosage Form Sales by Country/Region (2019-2024) & (Kiloton)
Table 31. Global Parenteral Dosage Form Sales Market Share by Country/Region (2019-2024)
Table 32. Global Parenteral Dosage Form Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Parenteral Dosage Form Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Parenteral Dosage Form Sales by Country (2019-2024) & (Kiloton)
Table 35. Americas Parenteral Dosage Form Sales Market Share by Country (2019-2024)
Table 36. Americas Parenteral Dosage Form Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Parenteral Dosage Form Revenue Market Share by Country (2019-2024)
Table 38. Americas Parenteral Dosage Form Sales by Type (2019-2024) & (Kiloton)
Table 39. Americas Parenteral Dosage Form Sales by Application (2019-2024) & (Kiloton)
Table 40. APAC Parenteral Dosage Form Sales by Region (2019-2024) & (Kiloton)
Table 41. APAC Parenteral Dosage Form Sales Market Share by Region (2019-2024)
Table 42. APAC Parenteral Dosage Form Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Parenteral Dosage Form Revenue Market Share by Region (2019-2024)
Table 44. APAC Parenteral Dosage Form Sales by Type (2019-2024) & (Kiloton)
Table 45. APAC Parenteral Dosage Form Sales by Application (2019-2024) & (Kiloton)
Table 46. Europe Parenteral Dosage Form Sales by Country (2019-2024) & (Kiloton)
Table 47. Europe Parenteral Dosage Form Sales Market Share by Country (2019-2024)
Table 48. Europe Parenteral Dosage Form Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Parenteral Dosage Form Revenue Market Share by Country (2019-2024)
Table 50. Europe Parenteral Dosage Form Sales by Type (2019-2024) & (Kiloton)
Table 51. Europe Parenteral Dosage Form Sales by Application (2019-2024) & (Kiloton)
Table 52. Middle East & Africa Parenteral Dosage Form Sales by Country (2019-2024) & (Kiloton)
Table 53. Middle East & Africa Parenteral Dosage Form Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Parenteral Dosage Form Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Parenteral Dosage Form Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Parenteral Dosage Form Sales by Type (2019-2024) & (Kiloton)
Table 57. Middle East & Africa Parenteral Dosage Form Sales by Application (2019-2024) & (Kiloton)
Table 58. Key Market Drivers & Growth Opportunities of Parenteral Dosage Form
Table 59. Key Market Challenges & Risks of Parenteral Dosage Form
Table 60. Key Industry Trends of Parenteral Dosage Form
Table 61. Parenteral Dosage Form Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Parenteral Dosage Form Distributors List
Table 64. Parenteral Dosage Form Customer List
Table 65. Global Parenteral Dosage Form Sales Forecast by Region (2025-2030) & (Kiloton)
Table 66. Global Parenteral Dosage Form Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Parenteral Dosage Form Sales Forecast by Country (2025-2030) & (Kiloton)
Table 68. Americas Parenteral Dosage Form Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Parenteral Dosage Form Sales Forecast by Region (2025-2030) & (Kiloton)
Table 70. APAC Parenteral Dosage Form Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Parenteral Dosage Form Sales Forecast by Country (2025-2030) & (Kiloton)
Table 72. Europe Parenteral Dosage Form Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Parenteral Dosage Form Sales Forecast by Country (2025-2030) & (Kiloton)
Table 74. Middle East & Africa Parenteral Dosage Form Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Parenteral Dosage Form Sales Forecast by Type (2025-2030) & (Kiloton)
Table 76. Global Parenteral Dosage Form Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Parenteral Dosage Form Sales Forecast by Application (2025-2030) & (Kiloton)
Table 78. Global Parenteral Dosage Form Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Ashland Basic Information, Parenteral Dosage Form Manufacturing Base, Sales Area and Its Competitors
Table 80. Ashland Parenteral Dosage Form Product Portfolios and Specifications
Table 81. Ashland Parenteral Dosage Form Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 82. Ashland Main Business
Table 83. Ashland Latest Developments
Table 84. Tepnel Pharma Services Basic Information, Parenteral Dosage Form Manufacturing Base, Sales Area and Its Competitors
Table 85. Tepnel Pharma Services Parenteral Dosage Form Product Portfolios and Specifications
Table 86. Tepnel Pharma Services Parenteral Dosage Form Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 87. Tepnel Pharma Services Main Business
Table 88. Tepnel Pharma Services Latest Developments
Table 89. Ascendia Pharmaceuticals Basic Information, Parenteral Dosage Form Manufacturing Base, Sales Area and Its Competitors
Table 90. Ascendia Pharmaceuticals Parenteral Dosage Form Product Portfolios and Specifications
Table 91. Ascendia Pharmaceuticals Parenteral Dosage Form Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 92. Ascendia Pharmaceuticals Main Business
Table 93. Ascendia Pharmaceuticals Latest Developments
Table 94. Thermo Fisher Scientific Basic Information, Parenteral Dosage Form Manufacturing Base, Sales Area and Its Competitors
Table 95. Thermo Fisher Scientific Parenteral Dosage Form Product Portfolios and Specifications
Table 96. Thermo Fisher Scientific Parenteral Dosage Form Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 97. Thermo Fisher Scientific Main Business
Table 98. Thermo Fisher Scientific Latest Developments
Table 99. ProJect Pharmaceutics Basic Information, Parenteral Dosage Form Manufacturing Base, Sales Area and Its Competitors
Table 100. ProJect Pharmaceutics Parenteral Dosage Form Product Portfolios and Specifications
Table 101. ProJect Pharmaceutics Parenteral Dosage Form Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 102. ProJect Pharmaceutics Main Business
Table 103. ProJect Pharmaceutics Latest Developments
Table 104. Lonza Basic Information, Parenteral Dosage Form Manufacturing Base, Sales Area and Its Competitors
Table 105. Lonza Parenteral Dosage Form Product Portfolios and Specifications
Table 106. Lonza Parenteral Dosage Form Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 107. Lonza Main Business
Table 108. Lonza Latest Developments
Table 109. BOC Sciences Basic Information, Parenteral Dosage Form Manufacturing Base, Sales Area and Its Competitors
Table 110. BOC Sciences Parenteral Dosage Form Product Portfolios and Specifications
Table 111. BOC Sciences Parenteral Dosage Form Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 112. BOC Sciences Main Business
Table 113. BOC Sciences Latest Developments
Table 1. Parenteral Dosage Form Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Parenteral Dosage Form Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Emulsions for Injection
Table 4. Major Players of Powders for Injection
Table 5. Major Players of Gels for Injection
Table 6. Global Parenteral Dosage Form Sales by Type (2019-2024) & (Kiloton)
Table 7. Global Parenteral Dosage Form Sales Market Share by Type (2019-2024)
Table 8. Global Parenteral Dosage Form Revenue by Type (2019-2024) & ($ million)
Table 9. Global Parenteral Dosage Form Revenue Market Share by Type (2019-2024)
Table 10. Global Parenteral Dosage Form Sale Price by Type (2019-2024) & (US$/Ton)
Table 11. Global Parenteral Dosage Form Sales by Application (2019-2024) & (Kiloton)
Table 12. Global Parenteral Dosage Form Sales Market Share by Application (2019-2024)
Table 13. Global Parenteral Dosage Form Revenue by Application (2019-2024)
Table 14. Global Parenteral Dosage Form Revenue Market Share by Application (2019-2024)
Table 15. Global Parenteral Dosage Form Sale Price by Application (2019-2024) & (US$/Ton)
Table 16. Global Parenteral Dosage Form Sales by Company (2019-2024) & (Kiloton)
Table 17. Global Parenteral Dosage Form Sales Market Share by Company (2019-2024)
Table 18. Global Parenteral Dosage Form Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Parenteral Dosage Form Revenue Market Share by Company (2019-2024)
Table 20. Global Parenteral Dosage Form Sale Price by Company (2019-2024) & (US$/Ton)
Table 21. Key Manufacturers Parenteral Dosage Form Producing Area Distribution and Sales Area
Table 22. Players Parenteral Dosage Form Products Offered
Table 23. Parenteral Dosage Form Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Parenteral Dosage Form Sales by Geographic Region (2019-2024) & (Kiloton)
Table 27. Global Parenteral Dosage Form Sales Market Share Geographic Region (2019-2024)
Table 28. Global Parenteral Dosage Form Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Parenteral Dosage Form Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Parenteral Dosage Form Sales by Country/Region (2019-2024) & (Kiloton)
Table 31. Global Parenteral Dosage Form Sales Market Share by Country/Region (2019-2024)
Table 32. Global Parenteral Dosage Form Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Parenteral Dosage Form Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Parenteral Dosage Form Sales by Country (2019-2024) & (Kiloton)
Table 35. Americas Parenteral Dosage Form Sales Market Share by Country (2019-2024)
Table 36. Americas Parenteral Dosage Form Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Parenteral Dosage Form Revenue Market Share by Country (2019-2024)
Table 38. Americas Parenteral Dosage Form Sales by Type (2019-2024) & (Kiloton)
Table 39. Americas Parenteral Dosage Form Sales by Application (2019-2024) & (Kiloton)
Table 40. APAC Parenteral Dosage Form Sales by Region (2019-2024) & (Kiloton)
Table 41. APAC Parenteral Dosage Form Sales Market Share by Region (2019-2024)
Table 42. APAC Parenteral Dosage Form Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Parenteral Dosage Form Revenue Market Share by Region (2019-2024)
Table 44. APAC Parenteral Dosage Form Sales by Type (2019-2024) & (Kiloton)
Table 45. APAC Parenteral Dosage Form Sales by Application (2019-2024) & (Kiloton)
Table 46. Europe Parenteral Dosage Form Sales by Country (2019-2024) & (Kiloton)
Table 47. Europe Parenteral Dosage Form Sales Market Share by Country (2019-2024)
Table 48. Europe Parenteral Dosage Form Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Parenteral Dosage Form Revenue Market Share by Country (2019-2024)
Table 50. Europe Parenteral Dosage Form Sales by Type (2019-2024) & (Kiloton)
Table 51. Europe Parenteral Dosage Form Sales by Application (2019-2024) & (Kiloton)
Table 52. Middle East & Africa Parenteral Dosage Form Sales by Country (2019-2024) & (Kiloton)
Table 53. Middle East & Africa Parenteral Dosage Form Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Parenteral Dosage Form Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Parenteral Dosage Form Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Parenteral Dosage Form Sales by Type (2019-2024) & (Kiloton)
Table 57. Middle East & Africa Parenteral Dosage Form Sales by Application (2019-2024) & (Kiloton)
Table 58. Key Market Drivers & Growth Opportunities of Parenteral Dosage Form
Table 59. Key Market Challenges & Risks of Parenteral Dosage Form
Table 60. Key Industry Trends of Parenteral Dosage Form
Table 61. Parenteral Dosage Form Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Parenteral Dosage Form Distributors List
Table 64. Parenteral Dosage Form Customer List
Table 65. Global Parenteral Dosage Form Sales Forecast by Region (2025-2030) & (Kiloton)
Table 66. Global Parenteral Dosage Form Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Parenteral Dosage Form Sales Forecast by Country (2025-2030) & (Kiloton)
Table 68. Americas Parenteral Dosage Form Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Parenteral Dosage Form Sales Forecast by Region (2025-2030) & (Kiloton)
Table 70. APAC Parenteral Dosage Form Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Parenteral Dosage Form Sales Forecast by Country (2025-2030) & (Kiloton)
Table 72. Europe Parenteral Dosage Form Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Parenteral Dosage Form Sales Forecast by Country (2025-2030) & (Kiloton)
Table 74. Middle East & Africa Parenteral Dosage Form Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Parenteral Dosage Form Sales Forecast by Type (2025-2030) & (Kiloton)
Table 76. Global Parenteral Dosage Form Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Parenteral Dosage Form Sales Forecast by Application (2025-2030) & (Kiloton)
Table 78. Global Parenteral Dosage Form Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Ashland Basic Information, Parenteral Dosage Form Manufacturing Base, Sales Area and Its Competitors
Table 80. Ashland Parenteral Dosage Form Product Portfolios and Specifications
Table 81. Ashland Parenteral Dosage Form Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 82. Ashland Main Business
Table 83. Ashland Latest Developments
Table 84. Tepnel Pharma Services Basic Information, Parenteral Dosage Form Manufacturing Base, Sales Area and Its Competitors
Table 85. Tepnel Pharma Services Parenteral Dosage Form Product Portfolios and Specifications
Table 86. Tepnel Pharma Services Parenteral Dosage Form Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 87. Tepnel Pharma Services Main Business
Table 88. Tepnel Pharma Services Latest Developments
Table 89. Ascendia Pharmaceuticals Basic Information, Parenteral Dosage Form Manufacturing Base, Sales Area and Its Competitors
Table 90. Ascendia Pharmaceuticals Parenteral Dosage Form Product Portfolios and Specifications
Table 91. Ascendia Pharmaceuticals Parenteral Dosage Form Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 92. Ascendia Pharmaceuticals Main Business
Table 93. Ascendia Pharmaceuticals Latest Developments
Table 94. Thermo Fisher Scientific Basic Information, Parenteral Dosage Form Manufacturing Base, Sales Area and Its Competitors
Table 95. Thermo Fisher Scientific Parenteral Dosage Form Product Portfolios and Specifications
Table 96. Thermo Fisher Scientific Parenteral Dosage Form Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 97. Thermo Fisher Scientific Main Business
Table 98. Thermo Fisher Scientific Latest Developments
Table 99. ProJect Pharmaceutics Basic Information, Parenteral Dosage Form Manufacturing Base, Sales Area and Its Competitors
Table 100. ProJect Pharmaceutics Parenteral Dosage Form Product Portfolios and Specifications
Table 101. ProJect Pharmaceutics Parenteral Dosage Form Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 102. ProJect Pharmaceutics Main Business
Table 103. ProJect Pharmaceutics Latest Developments
Table 104. Lonza Basic Information, Parenteral Dosage Form Manufacturing Base, Sales Area and Its Competitors
Table 105. Lonza Parenteral Dosage Form Product Portfolios and Specifications
Table 106. Lonza Parenteral Dosage Form Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 107. Lonza Main Business
Table 108. Lonza Latest Developments
Table 109. BOC Sciences Basic Information, Parenteral Dosage Form Manufacturing Base, Sales Area and Its Competitors
Table 110. BOC Sciences Parenteral Dosage Form Product Portfolios and Specifications
Table 111. BOC Sciences Parenteral Dosage Form Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 112. BOC Sciences Main Business
Table 113. BOC Sciences Latest Developments
LIST OF FIGURES
Figure 1. Picture of Parenteral Dosage Form
Figure 2. Parenteral Dosage Form Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Parenteral Dosage Form Sales Growth Rate 2019-2030 (Kiloton)
Figure 7. Global Parenteral Dosage Form Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Parenteral Dosage Form Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Emulsions for Injection
Figure 10. Product Picture of Powders for Injection
Figure 11. Product Picture of Gels for Injection
Figure 12. Global Parenteral Dosage Form Sales Market Share by Type in 2023
Figure 13. Global Parenteral Dosage Form Revenue Market Share by Type (2019-2024)
Figure 14. Parenteral Dosage Form Consumed in Hospital
Figure 15. Global Parenteral Dosage Form Market: Hospital (2019-2024) & (Kiloton)
Figure 16. Parenteral Dosage Form Consumed in Clinic
Figure 17. Global Parenteral Dosage Form Market: Clinic (2019-2024) & (Kiloton)
Figure 18. Parenteral Dosage Form Consumed in Others
Figure 19. Global Parenteral Dosage Form Market: Others (2019-2024) & (Kiloton)
Figure 20. Global Parenteral Dosage Form Sales Market Share by Application (2023)
Figure 21. Global Parenteral Dosage Form Revenue Market Share by Application in 2023
Figure 22. Parenteral Dosage Form Sales Market by Company in 2023 (Kiloton)
Figure 23. Global Parenteral Dosage Form Sales Market Share by Company in 2023
Figure 24. Parenteral Dosage Form Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Parenteral Dosage Form Revenue Market Share by Company in 2023
Figure 26. Global Parenteral Dosage Form Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Parenteral Dosage Form Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Parenteral Dosage Form Sales 2019-2024 (Kiloton)
Figure 29. Americas Parenteral Dosage Form Revenue 2019-2024 ($ Millions)
Figure 30. APAC Parenteral Dosage Form Sales 2019-2024 (Kiloton)
Figure 31. APAC Parenteral Dosage Form Revenue 2019-2024 ($ Millions)
Figure 32. Europe Parenteral Dosage Form Sales 2019-2024 (Kiloton)
Figure 33. Europe Parenteral Dosage Form Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Parenteral Dosage Form Sales 2019-2024 (Kiloton)
Figure 35. Middle East & Africa Parenteral Dosage Form Revenue 2019-2024 ($ Millions)
Figure 36. Americas Parenteral Dosage Form Sales Market Share by Country in 2023
Figure 37. Americas Parenteral Dosage Form Revenue Market Share by Country in 2023
Figure 38. Americas Parenteral Dosage Form Sales Market Share by Type (2019-2024)
Figure 39. Americas Parenteral Dosage Form Sales Market Share by Application (2019-2024)
Figure 40. United States Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Parenteral Dosage Form Sales Market Share by Region in 2023
Figure 45. APAC Parenteral Dosage Form Revenue Market Share by Regions in 2023
Figure 46. APAC Parenteral Dosage Form Sales Market Share by Type (2019-2024)
Figure 47. APAC Parenteral Dosage Form Sales Market Share by Application (2019-2024)
Figure 48. China Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Parenteral Dosage Form Sales Market Share by Country in 2023
Figure 56. Europe Parenteral Dosage Form Revenue Market Share by Country in 2023
Figure 57. Europe Parenteral Dosage Form Sales Market Share by Type (2019-2024)
Figure 58. Europe Parenteral Dosage Form Sales Market Share by Application (2019-2024)
Figure 59. Germany Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Parenteral Dosage Form Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Parenteral Dosage Form Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Parenteral Dosage Form Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Parenteral Dosage Form Sales Market Share by Application (2019-2024)
Figure 68. Egypt Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Parenteral Dosage Form in 2023
Figure 74. Manufacturing Process Analysis of Parenteral Dosage Form
Figure 75. Industry Chain Structure of Parenteral Dosage Form
Figure 76. Channels of Distribution
Figure 77. Global Parenteral Dosage Form Sales Market Forecast by Region (2025-2030)
Figure 78. Global Parenteral Dosage Form Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Parenteral Dosage Form Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Parenteral Dosage Form Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Parenteral Dosage Form Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Parenteral Dosage Form Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Parenteral Dosage Form
Figure 2. Parenteral Dosage Form Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Parenteral Dosage Form Sales Growth Rate 2019-2030 (Kiloton)
Figure 7. Global Parenteral Dosage Form Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Parenteral Dosage Form Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Emulsions for Injection
Figure 10. Product Picture of Powders for Injection
Figure 11. Product Picture of Gels for Injection
Figure 12. Global Parenteral Dosage Form Sales Market Share by Type in 2023
Figure 13. Global Parenteral Dosage Form Revenue Market Share by Type (2019-2024)
Figure 14. Parenteral Dosage Form Consumed in Hospital
Figure 15. Global Parenteral Dosage Form Market: Hospital (2019-2024) & (Kiloton)
Figure 16. Parenteral Dosage Form Consumed in Clinic
Figure 17. Global Parenteral Dosage Form Market: Clinic (2019-2024) & (Kiloton)
Figure 18. Parenteral Dosage Form Consumed in Others
Figure 19. Global Parenteral Dosage Form Market: Others (2019-2024) & (Kiloton)
Figure 20. Global Parenteral Dosage Form Sales Market Share by Application (2023)
Figure 21. Global Parenteral Dosage Form Revenue Market Share by Application in 2023
Figure 22. Parenteral Dosage Form Sales Market by Company in 2023 (Kiloton)
Figure 23. Global Parenteral Dosage Form Sales Market Share by Company in 2023
Figure 24. Parenteral Dosage Form Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Parenteral Dosage Form Revenue Market Share by Company in 2023
Figure 26. Global Parenteral Dosage Form Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Parenteral Dosage Form Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Parenteral Dosage Form Sales 2019-2024 (Kiloton)
Figure 29. Americas Parenteral Dosage Form Revenue 2019-2024 ($ Millions)
Figure 30. APAC Parenteral Dosage Form Sales 2019-2024 (Kiloton)
Figure 31. APAC Parenteral Dosage Form Revenue 2019-2024 ($ Millions)
Figure 32. Europe Parenteral Dosage Form Sales 2019-2024 (Kiloton)
Figure 33. Europe Parenteral Dosage Form Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Parenteral Dosage Form Sales 2019-2024 (Kiloton)
Figure 35. Middle East & Africa Parenteral Dosage Form Revenue 2019-2024 ($ Millions)
Figure 36. Americas Parenteral Dosage Form Sales Market Share by Country in 2023
Figure 37. Americas Parenteral Dosage Form Revenue Market Share by Country in 2023
Figure 38. Americas Parenteral Dosage Form Sales Market Share by Type (2019-2024)
Figure 39. Americas Parenteral Dosage Form Sales Market Share by Application (2019-2024)
Figure 40. United States Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Parenteral Dosage Form Sales Market Share by Region in 2023
Figure 45. APAC Parenteral Dosage Form Revenue Market Share by Regions in 2023
Figure 46. APAC Parenteral Dosage Form Sales Market Share by Type (2019-2024)
Figure 47. APAC Parenteral Dosage Form Sales Market Share by Application (2019-2024)
Figure 48. China Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Parenteral Dosage Form Sales Market Share by Country in 2023
Figure 56. Europe Parenteral Dosage Form Revenue Market Share by Country in 2023
Figure 57. Europe Parenteral Dosage Form Sales Market Share by Type (2019-2024)
Figure 58. Europe Parenteral Dosage Form Sales Market Share by Application (2019-2024)
Figure 59. Germany Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Parenteral Dosage Form Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Parenteral Dosage Form Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Parenteral Dosage Form Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Parenteral Dosage Form Sales Market Share by Application (2019-2024)
Figure 68. Egypt Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Parenteral Dosage Form Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Parenteral Dosage Form in 2023
Figure 74. Manufacturing Process Analysis of Parenteral Dosage Form
Figure 75. Industry Chain Structure of Parenteral Dosage Form
Figure 76. Channels of Distribution
Figure 77. Global Parenteral Dosage Form Sales Market Forecast by Region (2025-2030)
Figure 78. Global Parenteral Dosage Form Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Parenteral Dosage Form Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Parenteral Dosage Form Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Parenteral Dosage Form Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Parenteral Dosage Form Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Upper Extremity Bone Fixation Screws Market Growth 2024-2030
US$ 3,660.00
March 2024
113 pages
Global Tracheotomy Tube Market Growth 2025-2031
US$ 3,660.00
August 2025
108 pages
Global Spinal Thoracolumbar Implants Market Growth 2024-2030
US$ 3,660.00
December 2024
89 pages
Global Constipation Treatment Drug Market Growth 2023-2029
US$ 3,660.00
March 2023
110 pages
Global Tysabri Drugs Market Growth 2024-2030
US$ 3,660.00
March 2024
78 pages
